Table 2 Comorbidities in IGS patients, expressed in number of patients n and percentage % (of the total amount of patients in which clinical characteristics were described in the article; 325 patients)
From: Imerslund-Gräsbeck syndrome: a comprehensive review of reported cases
Comorbidity | n | % |
|---|---|---|
Urinary tract | 18 | 5.5 |
Anatomical urinary tract anomalies | 10 | 3 |
Alport syndrome | 1 | 0.3 |
Focal segmental glomerulosclerosis | 4 | 1.2 |
IgA nephropathy grade I | 1 | 0.3 |
Membranous glomerulonephritis | 1 | 0.3 |
Vesico-urethral reflux grade II | 1 | 0.3 |
Haematological | 11 | 3.4 |
Alpha thalassemia | 2 | 0.6 |
Alpha thalassemia trait | 2 | 0.6 |
Bèta thalassemia | 2 | 0.6 |
Bèta thalassemia trait | 1 | 0.3 |
Defective neutrophil function | 3 | 0.9 |
Sickle anemia | 1 | 0.3 |
Immunological/endocrine disorders | 11 | 3.4 |
Congenital adrenal hyperplasia | 1 | 0.3 |
Congenital hypothyroidy | 1 | 0.3 |
Eosinophilic enterocolitis | 2 | 0.6 |
Fanconi anemia | 1 | 0.3 |
Gluten intolerance | 1 | 0.3 |
IgA deficiency | 3 | 0.9 |
Type I diabetes | 2 | 0.6 |
Ophthalmological abnormalities | 3 | 0.9 |
Cataract | 1 | 0.3 |
Partial atrophy of optic nerves | 1 | 0.3 |
Congenital retinal atrophy | 1 | 0.3 |
Other | 10 | 3 |
Gastroschisis | 1 | 0.3 |
Prematurity | 3 | 0.9 |
Pulmonary tuberculosis | 2 | 0.6 |
Rectal polyp | 1 | 0.3 |
Right-side heart failure | 1 | 0.3 |
Trisomy 21 | 1 | 0.3 |
Thrombotic microangiopathy | 1 | 0.3 |